Pharma channel feed – Endpoints News

Pharma channel feed

EMA rejects FDA-approved Parkinson's drug, signs off on Moderna vaccine use in adolescents ahead of FDA

4 years ago

Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty

4 years ago

6 top drugmakers offer perspectives on FDA's new covariates in RCTs guidance

4 years ago

Biogen has a shaky end to H1 with a $542M write-off adding to its woes — but analysts see big revenue ahead for Aduhelm

4 years ago

Biogen defends slow rollout of new Alzheimer's drug, criticizes negative media attention

4 years ago

Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer

4 years ago

Inside Biogen's scramble to sell Aduhelm: Project 'Javelin' and pressure to ID as many patients as possible

4 years ago

In 60 days, most insurers will be required to cover HIV prevention drugs and related services with no cost-sharing

4 years ago

How cozy is too cozy? FDA and Biogen offer up a test case

4 years ago

FDA rejects professor’s petition seeking to pull ‘dangerous’ Otsuka kidney disease drug

4 years ago

Terms of mega opioid settlement set to be disclosed this week — report

4 years ago

Merck KGaA fortifies its ‘site of the future’ with $319M research, staff training centers

4 years ago

FDA’s domestic biopharma inspections return to normal as agency faces backlog of 8,000+

4 years ago

AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer

4 years ago

Regeneron, already an institution in NY, earns Cuomo's backing for a $1.8B expansion at Tarrytown hive

4 years ago

Bristol Myers Squibb takes another late-stage loss for Opdivo-Yervoy combo in head and neck cancer

4 years ago

Pfizer settles EpiPen price hike lawsuits for $345M

4 years ago

Safety concerns push FDA adcomm to vote overwhelmingly against approval for FibroGen anemia drug

4 years ago

Major health systems refuse to administer Aduhelm as top FDA leaders meet behind closed doors to talk with payers

4 years ago

FDA chides Amgen over misleading banner ad for Neulasta

4 years ago

FDA mulls regulatory action on Sprout's 'female Viagra' after adverse events spike

4 years ago

In reversal, employers, union groups push for Congress to allow Medicare to negotiate drug prices

4 years ago

House committees kick off investigation into how Biogen's Aduhelm won approval

4 years ago

CMS kicks off 9-month process on whether to limit coverage to Biogen's new Alzheimer's drug

4 years ago

First page Previous page 240 241 242243244 245 246 Next page Last page